Latest topics
What is the most important information I should know about Bextra?
Page 1 of 1
What is the most important information I should know about Bextra?
Bextra was withdrawn from the U.S. market in 2005.
The manufacturer of Bextra has announced the voluntary withdrawal of
the drug from the U.S. market. This withdrawal is due to safety concerns
of an increased risk of cardiovascular events (including heart attack
and stroke) in patients taking non-steroidal anti-inflammatory drugs
(Bextra is a "COX-2" selective non-steroidal anti-inflammatory drug) and
safety concerns of an increased risk of rare but serious skin reactions
in patients taking Bextra.
Do not take Bextra without first talking to your doctor if you have
experienced asthma, hives, or an allergic reaction after taking a
sulfa-based medication such as sulfamethoxazole (Bactrim, Septra,
Gantanol, and others) or sulfisoxazole (Gantrisin); aspirin; or another
NSAID such as celecoxib (Celebrex), ibuprofen (Motrin, Advil, Nuprin,
and others), naproxen (Aleve, Naprosyn, Anaprox), ketoprofen (Orudis KT,
Orudis, Oruvail), diclofenac (Voltaren, Cataflam), diflunisal
(Dolobid), etodolac (Lodine, Lodine XL), fenoprofen (Nalfon),
flurbiprofen (Ansaid), indomethacin (Indocin), ketorolac (Toradol),
meloxicam (Mobic), nabumetone (Relafen), oxaprozin (Daypro), piroxicam
(Feldene), sulindac (Clinoril), or tolmetin (Tolectin). You may
experience a similar reaction to Bextra. Notify your doctor immediately
if you develop abdominal pain, tenderness, or discomfort; nausea; bloody
vomit; bloody, black, or tarry stools; unexplained weight gain;
swelling or water retention; fatigue or lethargy; a skin rash; itching;
yellowing of the skin or eyes;"flu-like" symptoms; or unusual bruising
or bleeding. These symptoms could be early signs of dangerous side
effects. Serious skin reactions have occurred in patients taking Bextra.
These reactions tend to occur within the first two weeks of treatment,
but may occur at any time during treatment. Stop taking Bextra and
contact your doctor immediately if you develop a skin rash; hives;
itching; difficulty breathing; swelling of the lips, tongue or face; or
other symptoms of an allergic reaction.
What is Bextra?
Bextra was withdrawn from the U.S. market in 2005.
Bextra is in a class of drugs called nonsteroidal anti-inflammatory
drugs (NSAIDs). Bextra works by reducing substances in the body that
cause inflammation, pain, and fever.
Bextra is used to reduce pain, inflammation, and stiffness caused by
osteoarthritis and adult rheumatoid arthritis. Bextra is also used to
treat painful menstruation.
Bextra may also be used for purposes other than those listed in this medication guide.
What should I discuss with my healthcare provider before taking Bextra?
The manufacturer of Bextra has announced the voluntary withdrawal of
the drug from the U.S. market. This withdrawal is due to safety concerns
of an increased risk of cardiovascular events (including heart attack
and stroke) in patients taking non-steroidal anti-inflammatory drugs
(Bextra is a "COX-2" selective non-steroidal anti-inflammatory drug) and
safety concerns of an increased risk of rare but serious skin reactions
in patients taking Bextra.
Do not take Bextra without first talking to your doctor if you have
experienced asthma, hives, or an allergic reaction after taking a
sulfa-based medication such as sulfamethoxazole (Bactrim, Septra,
Gantanol, and others) or sulfisoxazole (Gantrisin); aspirin; or another
NSAID such as celecoxib (Celebrex), ibuprofen (Motrin, Advil, Nuprin,
and others), naproxen (Aleve, Naprosyn, Anaprox), ketoprofen (Orudis KT,
Orudis, Oruvail), diclofenac (Voltaren, Cataflam), diflunisal
(Dolobid), etodolac (Lodine, Lodine XL), fenoprofen (Nalfon),
flurbiprofen (Ansaid), indomethacin (Indocin), ketorolac (Toradol),
meloxicam (Mobic), nabumetone (Relafen), oxaprozin (Daypro), piroxicam
(Feldene), sulindac (Clinoril), or tolmetin (Tolectin). You may
experience a similar reaction to Bextra.
Bextra should not be used for the treatment of pain after coronary
artery bypass surgery (CABG). The use of Bextra in such patients has led
to an increased incidence of cardiovascular events, deep surgical
infections and wound complications. Talk to your doctor before taking
Bextra if you are being treated for pain associated with CABG.
Before taking Bextra, tell your doctor if you
You may not be able to take Bextra, or you may require a dosage
adjustment or special monitoring during treatment if you have any of the
conditions, or are taking any of the medicines, listed above.
Bextra is in the FDA pregnancy category C. This means that it is not
known whether it will be harmful to an unborn baby. Bextra should not be
taken late in pregnancy (the third trimester) because it may affect the
formation of the baby's heart. Do not take Bextra without first talking
to your doctor if you are pregnant or could become pregnant during
treatment. It is not known whether Bextra passes into breast milk. Do
not take Bextra without first talking to your doctor if you are
breast-feeding a baby. If you are over the age of 65 years, you may be
more likely to experience side effects from Bextra. You may require a
lower dosage or special monitoring during your therapy.
The manufacturer of Bextra has announced the voluntary withdrawal of
the drug from the U.S. market. This withdrawal is due to safety concerns
of an increased risk of cardiovascular events (including heart attack
and stroke) in patients taking non-steroidal anti-inflammatory drugs
(Bextra is a "COX-2" selective non-steroidal anti-inflammatory drug) and
safety concerns of an increased risk of rare but serious skin reactions
in patients taking Bextra.
Do not take Bextra without first talking to your doctor if you have
experienced asthma, hives, or an allergic reaction after taking a
sulfa-based medication such as sulfamethoxazole (Bactrim, Septra,
Gantanol, and others) or sulfisoxazole (Gantrisin); aspirin; or another
NSAID such as celecoxib (Celebrex), ibuprofen (Motrin, Advil, Nuprin,
and others), naproxen (Aleve, Naprosyn, Anaprox), ketoprofen (Orudis KT,
Orudis, Oruvail), diclofenac (Voltaren, Cataflam), diflunisal
(Dolobid), etodolac (Lodine, Lodine XL), fenoprofen (Nalfon),
flurbiprofen (Ansaid), indomethacin (Indocin), ketorolac (Toradol),
meloxicam (Mobic), nabumetone (Relafen), oxaprozin (Daypro), piroxicam
(Feldene), sulindac (Clinoril), or tolmetin (Tolectin). You may
experience a similar reaction to Bextra. Notify your doctor immediately
if you develop abdominal pain, tenderness, or discomfort; nausea; bloody
vomit; bloody, black, or tarry stools; unexplained weight gain;
swelling or water retention; fatigue or lethargy; a skin rash; itching;
yellowing of the skin or eyes;"flu-like" symptoms; or unusual bruising
or bleeding. These symptoms could be early signs of dangerous side
effects. Serious skin reactions have occurred in patients taking Bextra.
These reactions tend to occur within the first two weeks of treatment,
but may occur at any time during treatment. Stop taking Bextra and
contact your doctor immediately if you develop a skin rash; hives;
itching; difficulty breathing; swelling of the lips, tongue or face; or
other symptoms of an allergic reaction.
What is Bextra?
Bextra was withdrawn from the U.S. market in 2005.
Bextra is in a class of drugs called nonsteroidal anti-inflammatory
drugs (NSAIDs). Bextra works by reducing substances in the body that
cause inflammation, pain, and fever.
Bextra is used to reduce pain, inflammation, and stiffness caused by
osteoarthritis and adult rheumatoid arthritis. Bextra is also used to
treat painful menstruation.
Bextra may also be used for purposes other than those listed in this medication guide.
What should I discuss with my healthcare provider before taking Bextra?
The manufacturer of Bextra has announced the voluntary withdrawal of
the drug from the U.S. market. This withdrawal is due to safety concerns
of an increased risk of cardiovascular events (including heart attack
and stroke) in patients taking non-steroidal anti-inflammatory drugs
(Bextra is a "COX-2" selective non-steroidal anti-inflammatory drug) and
safety concerns of an increased risk of rare but serious skin reactions
in patients taking Bextra.
Do not take Bextra without first talking to your doctor if you have
experienced asthma, hives, or an allergic reaction after taking a
sulfa-based medication such as sulfamethoxazole (Bactrim, Septra,
Gantanol, and others) or sulfisoxazole (Gantrisin); aspirin; or another
NSAID such as celecoxib (Celebrex), ibuprofen (Motrin, Advil, Nuprin,
and others), naproxen (Aleve, Naprosyn, Anaprox), ketoprofen (Orudis KT,
Orudis, Oruvail), diclofenac (Voltaren, Cataflam), diflunisal
(Dolobid), etodolac (Lodine, Lodine XL), fenoprofen (Nalfon),
flurbiprofen (Ansaid), indomethacin (Indocin), ketorolac (Toradol),
meloxicam (Mobic), nabumetone (Relafen), oxaprozin (Daypro), piroxicam
(Feldene), sulindac (Clinoril), or tolmetin (Tolectin). You may
experience a similar reaction to Bextra.
Bextra should not be used for the treatment of pain after coronary
artery bypass surgery (CABG). The use of Bextra in such patients has led
to an increased incidence of cardiovascular events, deep surgical
infections and wound complications. Talk to your doctor before taking
Bextra if you are being treated for pain associated with CABG.
Before taking Bextra, tell your doctor if you
smoke;
drink alcohol;
have an ulcer or bleeding in the stomach;- have liver disease;
- have kidney disease;
have asthma;
have congestive heart failure;
have fluid retention;
have heart disease;
have high blood pressure;
have a coagulation (bleeding) disorder or are taking an anticoagulant (blood thinner) such as warfarin (Coumadin); or
are taking a steroid medicine such as prednisone (Deltasone and
others), methylprednisolone (Medrol and others), prednisolone (Prelone,
Pediapred, and others), and others.
You may not be able to take Bextra, or you may require a dosage
adjustment or special monitoring during treatment if you have any of the
conditions, or are taking any of the medicines, listed above.
Bextra is in the FDA pregnancy category C. This means that it is not
known whether it will be harmful to an unborn baby. Bextra should not be
taken late in pregnancy (the third trimester) because it may affect the
formation of the baby's heart. Do not take Bextra without first talking
to your doctor if you are pregnant or could become pregnant during
treatment. It is not known whether Bextra passes into breast milk. Do
not take Bextra without first talking to your doctor if you are
breast-feeding a baby. If you are over the age of 65 years, you may be
more likely to experience side effects from Bextra. You may require a
lower dosage or special monitoring during your therapy.
Similar topics
» Financing Information
» Basic Information Regarding An Affiliate Program And All That It Is About
» Why keyword density is important ?
» Basic Information Covering What An Affiliate Program Can Help You To Achieve
» Basic Information Regarding An Affiliate Program And All That It Is About
» Why keyword density is important ?
» Basic Information Covering What An Affiliate Program Can Help You To Achieve
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|
Fri Aug 24, 2012 5:21 am by Admin
» خصومات 70 % على جميع السلع فى السعودية والخليج من موقع سكر فى رمضان والتوصيل مجانا
Fri Aug 10, 2012 4:34 pm by Admin
» Affiliate Marketing In 3 Steps
Mon Aug 06, 2012 3:46 am by Admin
» 5 Qualities For Affiliate Marketing
Mon Aug 06, 2012 3:41 am by Admin
» 2 Types Of Graduate Loans
Mon Jul 30, 2012 10:51 am by Admin
» 1st And 2nd Mortgage Refinance Loan - Why Refinance Both Mortgages?
Mon Jul 30, 2012 10:50 am by Admin
» Creating Unique Sites for Affiliate Marketing
Mon Jul 30, 2012 10:44 am by Admin
» Affiliate Markets Saturation
Mon Jul 30, 2012 10:42 am by Admin
» How to Be an Affiliate Marketing Rockstar?
Mon Jul 30, 2012 10:40 am by Admin